Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial
Clinical trial NCT04881825 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04881825
- Sponsor
- Zealand Pharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2026-04-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.